Whitepaper: Expanding solutions for challenging APIs
Posted: 1 June 2021 | ADARE Pharma Solutions | No comments yet
Coacervation is part art, part science, and when done properly by an experienced and knowledgeable team, it is an elegant solution for a variety of formation issues. Adare’s primary method for solvent coacervation platform, Microcaps, is unique in the pharmaceutical industry and provides developers a variety of delivery options including capsules, traditional tablets, ODTs, stick packs, reconstitutable suspensions, and more.
Related content from this organisation
- EPR Podcast Episode 26 – Navigating Nitrosamine Impurities – Jason Brown, Adare Pharma Solutions
- Maintaining EU MDR certification: a spotlight on post‑market clinical follow-up
- Formulation, Development & Delivery In-Depth Focus 2021
- Scientific briefing: Formulation-Monodisperse CR quetiapine microspheres
- Scientific briefing: Formulation of aqueous core poly (lactic acid) microcapsules
Related topics
Analytical techniques, Biopharmaceuticals, Excipients, Formulation, Good Manufacturing Practice (GMP), Ingredients, Manufacturing, Research & Development (R&D)